| Customization: | Available |
|---|---|
| Varieties: | Parasite Disease Prevention Medicine |
| Component: | Chemical Synthetic Drugs |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Other name: Doxycycline hydrochloride; Doxycycline HCL
Appearance: a light blue or yellow crystalline powder,
Certificate: GMP&ISO
Sample: Available
Packing: 25kg/drum
Preparations: 10%/20% Doxycycline HCL soluble powder; Compound doxycycline HCL premix, Compound doxycycline HCL soluble powder
Doxycycline Hyclate
Doxycycline Hyclate (also known as doxycycline hydrochloride) is a light blue or yellow crystalline powder, odorless and bitter, hygroscopic, soluble in water and methanol, slightly soluble in ethanol and acetone . This product has a broad antibacterial spectrum and is effective against Gram-positive cocci and negative bacilli. The antibacterial effect is about 10 times stronger than that of tetracycline, and it is still effective against tetracycline-resistant bacteria. Mainly used for respiratory tract infections, chronic bronchitis, pneumonia and urinary tract infections, etc., but also for typhus, typhoid, and mycoplasma pneumonia.
Indications
Mainly used for upper respiratory tract infection, tonsillitis, biliary tract infection, lymphadenitis, cellulitis, chronic bronchitis, pneumonia and urinary tract infections, etc. caused by sensitive gram-positive cocci and gram-negative bacilli, also used for typhus, Tsutsugamushi disease, Mycoplasma pneumonia, etc. It can still be used to treat cholera, and it can also be used to prevent falciparum malaria and Leptospirosis infection.
Specification
CVP/EP
Packing
25kg/cardboard drum
Preparations
10%, 20% Doxycycline HCL soluble powder; Compound doxycycline hcl premix, Compound doxycycline hcl soluble powder
Company Profile
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation-based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own-label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific managemen. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
Veyong takes "Maintain animal health, improve quality of life" as the mission, strives to become the most valuable veterinary drug brand, and looks forward to active cooperation with global customers.
Company Profile
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation-based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own-label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific managemen. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
Veyong takes "Maintain animal health, improve quality of life" as the mission, strives to become the most valuable veterinary drug brand, and looks forward to active cooperation with global customers.
){kind=link}